|
Isavuconazole Impurity 105
|
艾沙康唑雜質(zhì)105
|
|
|
Dapagliflozin Impurity 135
|
達(dá)格列凈雜質(zhì)135
|
1971128-00-3
|
|
Dapagliflozin Impurity 136
|
達(dá)格列凈雜質(zhì)136
|
|
|
Dapagliflozin Impurity 137
|
達(dá)格列凈雜質(zhì)137
|
4376-18-5
|
|
Dapagliflozin Impurity 138
|
達(dá)格列凈雜質(zhì)138
|
1246819-50-0
|
|
Isavuconazole Impurity 108
|
艾沙康唑雜質(zhì)108
|
|
|
Isavuconazole Impurity 109
|
艾沙康唑雜質(zhì)109
|
|
|
2-Methylhexanoic Acid
|
2-甲基己酸
|
4536-23-6
|
|
N-Nitrososarcosine
|
N-亞硝基肌氨酸
|
13256-22-9
|
|
Isoacteoside
|
異麥角甾苷
|
61303-13-7
|
|
3,3'-Oxydiphenol
|
3,3'-氧二酚
|
7034-31-3
|
|
2-Naphthol-6,8-Disulfonic Acid
|
2-萘酚-6,8-二磺酸
|
118-32-1
|
|
2-Chloroacetic Acid Hydrazide
|
2-氯乙酸酰肼
|
30956-28-6
|
|
Bicyclol
|
雙環(huán)醇
|
118159-48-1
|
|
Cyclo(-Ala-Gln)
|
環(huán)(-丙氨酰胺-谷氨酰胺)
|
268221-76-7
|
|
Cyclo(-Ala-Glu)
|
環(huán)(-丙氨酰胺-谷氨酰胺)
|
16364-36-6
|
|
Nintedanib Impurity 73
|
尼達(dá)尼布雜質(zhì)73
|
54699-92-2
|
|
Levocarnitine Impurity 13
|
左卡尼汀雜質(zhì)13
|
127913-44-4
|
|
Neostigmine bromide Impurity 4
|
新斯的明溴化物雜質(zhì) 4
|
19962-04-0
|
|
Rivastigmine Impurity 21
|
卡巴拉汀雜質(zhì)21
|
1346242-34-9
|
|
Mirabegron impurity 95
|
米拉貝隆雜質(zhì)95
|
391901-43-2
|
|
Mirabegron Impurity 87
|
米拉貝隆雜質(zhì)87
|
1627515-83-6
|
|
Mirabegron Impurity 78
|
米拉貝隆雜質(zhì)78
|
|
|
Mirabegron Impurity 38
|
米拉貝隆雜質(zhì)38
|
|
|
Montelukast Impurity 39
|
孟魯司特雜質(zhì)39
|
769-28-8
|
|
Clopidogrel Metabolite II (Mixture of Diastereomers)
|
二氯吡格雷代謝物(非對(duì)映體的混合物)
|
1287430-40-3
|
|
Crizotinib impurity 25
|
克唑替尼雜質(zhì)25
|
|
|
Vonoprazan Impurity 8
|
沃諾拉贊雜質(zhì)8
|
|
|
Choline Fenofibrate Impurity 25
|
膽堿非諾貝特雜質(zhì)25
|
|
|
Baclofen impurity 43
|
巴氯芬雜質(zhì)43
|
|
|
Febuxostat-d7
|
非布索坦-d7
|
1285539-74-3
|
|
Isavuconazole Impurity 58
|
艾沙康唑雜質(zhì)58
|
36776-32-6
|
|
Afatinib Dimaleate
|
雙馬來(lái)酸阿法替尼
|
850140-73-7
|
|
Erythromycin Lactobionate
|
乳糖酸紅霉素
|
3847-29-8
|
|
(2-OXO-2-PHENYL-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER
|
(S)-芐基 1-(甲氧基(甲基)氨基)-1-氧代丙烷-2-基氨基甲酸酯
|
114744-83-1
|
|
5-chloro-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
|
5-氯-2-羥基-4,6-二甲基煙腈
|
23819-92-3
|
|
2-Butene-1,4-diol(cis+trans)
|
1,4-丁烯二醇（反式+順式）
|
110-64-5
|
|
4-Hydroxy-3-methoxy-5-nitrobenzoic acid
|
4-羥基-3-甲氧基-5-硝基苯甲酸
|
15785-54-3
|
|
Norepinephrine Impurity 66 HCl
|
去甲腎上腺素雜質(zhì)66 HCl
|
62-22-6
|
|
Folic Acid Impurity 40 HCl
|
葉酸雜質(zhì)40 鹽酸鹽
|
|
|
Rivaroxaban Impurity 4
|
利伐沙班雜質(zhì)4
|
446292-10-0
|
|
Fmoc-β-Ala-Gly-OH
|
芴甲氧羰基-beta-丙氨酸-甘氨酸-OH
|
133368-47-5
|
|
Efinaconazole Impurity 35
|
艾氟康唑雜質(zhì)35
|
127001-03-0
|
|
Solifenacin EP impurity A
|
索非那新EP雜質(zhì)A
|
118864-75-8
|
|
Dabigatran Impurity 11
|
達(dá)比加群雜質(zhì)11
|
1610758-20-7
|
|
Rivastigmine Impurity N1
|
卡巴拉汀雜質(zhì)N1
|
1369779-38-3
|
|
Selexipag Impurity 5
|
賽樂(lè)西帕雜質(zhì)5
|
2287345-22-4
|
|
Dapoxetine Impurity 61
|
達(dá)泊西汀雜質(zhì)61
|
|
|
Selexipag Impurity 31
|
賽樂(lè)西帕雜質(zhì)31
|
41270-66-0
|
|
Verapamil Impurity 35 HCl
|
維拉帕米雜質(zhì)35 鹽酸鹽
|
77326-93-3
|
|
Butylphthalide Impurity 11
|
丁苯酞雜質(zhì)11
|
111943-62-5
|
|
Selexipag Impurity 8
|
賽樂(lè)西帕雜質(zhì)8
|
475084-96-9
|
|
Selexipag Impurity 14
|
賽樂(lè)西帕雜質(zhì)14
|
475086-28-3
|
|
Brivanib
|
布立尼布
|
649735-46-6
|
|
Trelagliptin Impurity 30
|
曲格列汀雜質(zhì)30
|
850649-61-5
|
|
Diiodomethane
|
二碘甲烷
|
75-11-6
|
|
Racecadotril EP Impurity C
|
消旋卡多曲EP雜質(zhì)C
|
124735-06-4
|
|
Axitinib impurity 46
|
阿西替尼雜質(zhì)46
|
261953-36-0
|
|
Fmoc-β-Ala-Gln(Trt)-OH
|
Fmoc-β-L-丙氨酰-L-谷氨酰胺(Trt)-OH
|
2411591-25-6
|
|
D-Glutamine
|
D-谷氨酰胺
|
5959-95-5
|
|
Tofacitinib Impurity 194
|
托法替尼雜質(zhì)194
|
1206824-85-2
|
|
Ticagrelor Impurity 67
|
替卡格雷雜質(zhì)67
|
1487958-68-8
|
|
Ticagrelor Impurity 11
|
替卡格雷雜質(zhì)11
|
2248538-63-6
|
|
Rivaroxaban Impurity 79
|
利伐沙班雜質(zhì)79
|
2097255-05-3
|
|
Rivaroxaban Impurity 165
|
利伐沙班雜質(zhì)165
|
148857-44-7
|
|
Tadalafil Impurity 134
|
他達(dá)拉非雜質(zhì)134
|
171596-43-3
|
|
Ambroxol Impurity 67
|
氨溴索雜質(zhì)67
|
|
|
Ilaprazole Impurity 102
|
艾普拉唑雜質(zhì)102
|
|
|
Everolimus Impurity 43
|
依維莫司雜質(zhì)43
|
769905-89-7
|
|
2,2,3,3,8,8,9,9-Octamethyl-4,7-dioxa-3,8-disiladecane
|
2,2,3,3,8,8,9,9-八甲基-4,7-二氧雜-3,8-二硅癸烷
|
66548-22-9
|
|
Everolimus Impurity 17
|
依維莫司雜質(zhì)17
|
253431-35-5
|
|
Omeprazole Impurity 24 Sodium Salt
|
奧美拉唑雜質(zhì)24鈉鹽
|
161796-77-6
|
|
Risperidone cis-N-oxide Impurity
|
利培酮順氮氧化物雜質(zhì)
|
|
|
Pramipexole
|
普拉克索
|
104632-26-0
|
|
Linagliptin Impurity 77
|
利格列汀雜質(zhì)77
|
1673546-62-7
|
|
Alogliptin Impurity 65
|
阿格列汀雜質(zhì)65
|
334618-23-4
|
|
Alogliptin Impurity 17
|
阿格列汀雜質(zhì)17
|
865758-96-9
|
|
Ezetimibe Impurity 97
|
依折麥布雜質(zhì)97
|
439113-83-4
|
|
Amlodipine Impurity 54
|
氨氯地平雜質(zhì)54
|
5183-78-8
|
|
Ilaprazole Impurity 104
|
艾普拉唑雜質(zhì)104
|
1298015-57-2
|
|
Ilaprazole Impurity 103
|
艾普拉唑雜質(zhì)103
|
|
|
Tadalafil Impurity 133
|
他達(dá)拉非雜質(zhì)133
|
171596-44-4
|
|
Levocetirizine Impurity 54 HCl
|
左西替利嗪雜質(zhì)54 鹽酸鹽
|
942132-30-1
|
|
Ibuprofen Impurity 83
|
布洛芬雜質(zhì)83
|
64622-21-5
|
|
Tofacitinib Impurity 196
|
托法替尼雜質(zhì)196
|
|
|
Diclofenac-d4
|
雙氯芬酸-d4
|
153466-65-0
|
|
Salmeterol EP Impurity G
|
沙美特羅EP雜質(zhì)G
|
2470130-36-8
|
|
Milnacipran Impurity 17
|
米那普侖雜質(zhì)17
|
|
|
Mirabegron impurity 97
|
米拉貝隆雜質(zhì)97
|
2184223-32-1
|
|
Levetiracetam Impurity 24
|
左乙拉西坦雜質(zhì)24
|
79194-54-0
|
|
Empagliflozin Impurity 220
|
恩格列凈雜質(zhì)220
|
|
|
Vortioxetine Impurity 98
|
沃替西汀雜質(zhì)98
|
1240670-87-4
|
|
Vortioxetine Impurity 83
|
沃替西汀雜質(zhì)83
|
591-50-4
|
|
Tedizolid Impurity 65
|
泰地唑胺雜質(zhì)65
|
380380-60-9
|
|
Tedizolid Impurity 61
|
特地唑胺雜質(zhì)61
|
656-65-5
|
|
Tofacitinib Impurity 158
|
托法替尼雜質(zhì)158
|
|
|
Linezolid Impurity 73
|
利奈唑胺雜質(zhì)73
|
|
|
Empagliflozin Impurity 219
|
恩格列凈雜質(zhì)219
|
|
|
Diclofenac Sodium Impurity 35
|
雙氯芬酸鈉雜質(zhì)35
|
13625-57-5
|
|
Tofacitinib Impurity 198
|
托法替尼雜質(zhì)198
|
2641343-91-9
|